As of 2025-12-25, the EV/EBITDA ratio of Clearpoint Neuro Inc (CLPT) is -19.15. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CLPT's latest enterprise value is 422.06 mil USD. CLPT's TTM EBITDA according to its financial statements is -22.04 mil USD. Dividing these 2 quantities gives us the above CLPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 19.4x - 22.0x | 21.0x |
| Forward P/E multiples | 21.8x - 24.6x | 22.9x |
| Fair Price | (15.82) - (16.01) | (15.96) |
| Upside | -209.2% - -210.5% | -210.1% |
| Date | EV/EBITDA |
| 2025-12-23 | -18.99 |
| 2025-12-22 | -19.31 |
| 2025-12-19 | -18.76 |
| 2025-12-18 | -18.02 |
| 2025-12-17 | -17.90 |
| 2025-12-16 | -18.25 |
| 2025-12-15 | -16.30 |
| 2025-12-12 | -16.75 |
| 2025-12-11 | -17.10 |
| 2025-12-10 | -17.29 |
| 2025-12-09 | -17.72 |
| 2025-12-08 | -18.07 |
| 2025-12-05 | -17.87 |
| 2025-12-04 | -18.57 |
| 2025-12-03 | -18.60 |
| 2025-12-02 | -17.60 |
| 2025-12-01 | -18.14 |
| 2025-11-28 | -19.11 |
| 2025-11-26 | -19.08 |
| 2025-11-25 | -19.30 |
| 2025-11-24 | -19.03 |
| 2025-11-21 | -18.25 |
| 2025-11-20 | -17.83 |
| 2025-11-19 | -18.48 |
| 2025-11-18 | -18.89 |
| 2025-11-17 | -18.77 |
| 2025-11-14 | -20.42 |
| 2025-11-13 | -20.51 |
| 2025-11-12 | -22.15 |
| 2025-11-11 | -23.08 |
| 2025-11-10 | -21.91 |
| 2025-11-07 | -20.93 |
| 2025-11-06 | -24.20 |
| 2025-11-05 | -22.51 |
| 2025-11-04 | -23.24 |
| 2025-11-03 | -25.24 |
| 2025-10-31 | -30.94 |
| 2025-10-30 | -31.56 |
| 2025-10-29 | -32.14 |
| 2025-10-28 | -36.01 |
| 2025-10-27 | -33.96 |
| 2025-10-24 | -32.99 |
| 2025-10-23 | -33.70 |
| 2025-10-22 | -32.38 |
| 2025-10-21 | -33.31 |
| 2025-10-20 | -36.47 |
| 2025-10-17 | -33.85 |
| 2025-10-16 | -33.72 |
| 2025-10-15 | -33.11 |
| 2025-10-14 | -34.73 |